Angela Santoni

Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.

Ettore Novellino, Andrea Brancale, Ilaria Granata, 2011, Journal of medicinal chemistry.

Attenuation of PI3K/Akt-Mediated Tumorigenic Signals through PTEN Activation by DNA Vaccine-Induced Anti-ErbB2 Antibodies

Federica Cavallo, Stefania Lanzardo, Guido Forni, 2010, The Journal of Immunology.

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

Pietro Ghezzi, Alberto Mantovani, Daniela Corda, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of Natural Killer Cell Activity

Ronald B. Herberman, A. Santoni, R. Herberman, 1984 .

Chemokines and glioma: Invasion and more

Giuseppe Sciumè, G. Bernardini, A. Santoni, 2010, Journal of Neuroimmunology.

Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity.

A. Santoni, F. Neri, D. Cosman, 2007, The Journal of general virology.

Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 in T Lymphocytes

Luigi Frati, L. Frati, A. Santoni, 2007, Molecular Pharmacology.

Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice

Alessandro Rosa, Cristina Limatola, C. Limatola, 2015, Nature Communications.

Senescent cells: Living or dying is a matter of NK cells

A. Santoni, F. Antonangeli, Alessandra Soriani, 2019, Journal of leukocyte biology.

Vitamin D3: a transcriptional modulator of the interferon‐γ gene

A. Santoni, M. Cippitelli, Angela Santoni, 1998 .